Back to OCLS Stock Lookup

OCLS – FDA

Feb 4, 2014 08:16 AM Oculus (OCLS) Receives CE Mark to Two Microcyn-Based Products
Dec 12, 2013 08:10 AM Oculus (OCLS) Microcyn-Based Scar Management Hydrogel Approved in Mexico
Dec 4, 2013 08:11 AM Oculus (OCLS) Microcyn Scar Management HydroGel Receives FDA 501(k) Clearance
Jul 2, 2013 08:15 AM Oculus (OCLS) Receives Patent in Mexico for RUT58-60
Jun 6, 2013 08:09 AM Oculus (OCLS) Enters License, Supply and Shared Services Agreements with Ruthigen
Apr 24, 2013 08:10 AM Oculus (OCLS) Receives Approval, Will Begin Selling Three Microcyn-Based Products
Apr 10, 2013 08:11 AM Oculus (OCLS) Announces Larger Product Rollout in Singapore, Malaysia
Mar 26, 2013 08:11 AM Oculus (OCLS) Dermacyn Receives CE Mark Reclassification
Dec 27, 2012 08:09 AM Oculus (OCLS) Issued U.S. Patent for Microcyn Tech in Skin Ulcer Treatment
Dec 24, 2012 08:12 AM Oculus (OCLS) Files to Reclassify CE Mark for Dermacyn
Sep 27, 2012 08:11 AM Oculus (OCLS) Reports Encouraging Data for Microcyn-Based Hydrogel on Atopic Dermatitis
Jul 10, 2012 08:13 AM Oculus (OCLS) Gets Chinese SFDA Approval for Microcyn Hydrogel
Jun 25, 2012 09:05 AM AmDerma Pharma, Oculus Innovative (OCLS) Enter Microcyn Technology Development Agreement
Feb 8, 2011 08:22 AM Oculus Innovative (OCLS) Receives New 501(k) Clearance for Epicyn HydroGel
Mar 10, 2010 08:13 AM Oculus Innovative Sciences (OCLS) Receives U.S. FDA 501(k) Clearance for Microcyn Skin and Wound HydroGel
Jul 13, 2009 08:32 AM Oculus Innovative Sciences (OCLS) Reaches Agreement with OroScience to Market Microcyn(R)-Based Oral Care Products in U.S., Canadian and European Markets
Jun 24, 2009 08:12 AM Oculus Innovative (OCLS) Confirms Effectiveness of Microcyn Technology at Inactivating the H1NI
Jun 19, 2009 08:37 AM Oculus Innovative (OCLS) Announces "Highly Encouraging" Results From Feasibility Study of Microcyn Hydrogel
Jun 4, 2009 08:24 AM FDA Clears Expanded Label Claim for Oculus Innovative Sciences' (OCLS) Lead Microcyn Wound Care Product
May 27, 2009 08:41 AM Oculus Innovative (OCLS) Receives FDA 510(k) Okay
May 4, 2009 08:40 AM Oculus Innovative Sciences (OCLS) Reports Significant Increase in Sales of its Approved Microcyn Product in Mexico as H1N1 Flu (Swine Flu) Spreads
Jun 17, 2008 08:12 AM Oculus Innovative Sciences (OCLS) Announces Development of a Microcyn Hydrogel Formulation
Apr 15, 2008 08:23 AM Oculus Innovative (OCLS) Announces Positive Data Published from Pakistan Study
Mar 27, 2008 03:10 PM Oculus Innovative (OCLS) Surges on Chinese Regulatory Approval
Feb 27, 2008 08:56 AM Oculus Innovative Sciences (OCLS) Announces Positive Top-Line Phase II Data with Microcyn(R) Technology
Mar 29, 2007 08:20 AM Oculus Innovative Sciences (OCLS) Initial Sites for Phase II Clinical Trial of Microcyn

Back to OCLS Stock Lookup